MISPA MAESTRO: Precision Redefined in HPLC Testing

Introduction

In an evolving landscape of diabetes and hemoglobinopathy diagnostics, laboratories demand reliable, fast, and accurate testing systems. MISPA MAESTRO, Agappe’s high-performance HPLC analyzer, is designed to meet this demand with unmatched precision, automation, and analytical power.

High Throughput, Minimal Downtime

MISPA MAESTRO supports continuous loading of up to 50 samples, reducing interruptions and enabling seamless workflow even during high sample volumes. With a test completion time of just 72 seconds, it enhances lab productivity without compromising quality.

Exceptional Precision & Stability

Achieving a CV of less than 1%, the system ensures unmatched reproducibility and reliability of results—crucial for HbA1c monitoring and clinical decision-making. The use of ion-exchange HPLC ensures high separation resolution of hemoglobin fractions and variants.

Automated Smart Workflow

Every aspect of the workflow has been optimized. Automatic sample mixing, quantitative transfer of hemolysing buffer, and sample barcode reading reduce manual errors and operator dependency. Sample cup, sample collection tubes, and emergency stat positions provide flexibility for different clinical settings.

Extended Clinical Application

Beyond routine HbA1c testing, MISPA MAESTRO enables quantification of minor fractions such as HbF, A1a, A1b, LA1c, and A0. It also detects key hemoglobin variants prevalent in India — including HbS, HbC, HbD, and HbE — empowering clinicians with deeper insights into hemoglobinopathies.

Visual Data for Confident Diagnosis

Colored chromatograms simplify interpretation and support visual verification, aiding in the identification of variant peaks. This is particularly valuable in diagnostic settings where hemoglobinopathies are suspected.

Built for the Future

MISPA MAESTRO is designed for integration into LIS and scalable for future expansions. Its robust software interface and onboard QC management make it a future-proof investment for diagnostic labs and hospitals